Using 505(b)(2) to Solve Shortfall from Generic Cliff.
- Published in:
- Applied Clinical Trials, 2015, v. 24, n. 6/7, p. 22
- By:
- Publication type:
- Article
Works matching Federal Food, Drug, and Cosmetic Act
Results: 226
1
2
INDEPENDENT DRUG TESTING TO ENSURE DRUG SAFETY AND EFFICACY.
- Published in:
- Journal of Health Care Law & Policy, 2015, v. 18, n. 1, p. 45
- By:
- Publication type:
- Article
3
FDA APPROVAL OF DRUGS AND DEVICES: PREEMPTION OF STATE LAWS FOR "PARALLEL" TORT CLAIMS.
- Published in:
- Journal of Health Care Law & Policy, 2015, v. 18, n. 1, p. 1
- By:
- Publication type:
- Article
4
When the Punishment Does Not Fit the Crime: Exclusions from Federal Health Care Programs Following Convictions Under the Responsible Corporate Officer Doctrine.
- Published in:
- George Washington Law Review, 2016, v. 84, n. 3, p. 776
- By:
- Publication type:
- Article
5
SHOT THROUGH THE HEART: THE FDA GIVES ALL HEALTH CARE COMPANY EXECUTIVES A BAD NAME UNDER THE CONTROVERSIAL STRICT-LIABILITY MISDEMEANOR PROVISION OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT.
- Published in:
- Brooklyn Journal of Corporate, Financial & Commercial Law, 2012, v. 6, n. 2, p. 593
- By:
- Publication type:
- Article
6
Can McKesson Obtain Much Needed Clarity in Unclaimed Property Administration?
- Published in:
- Journal of State Taxation, 2010, v. 28, n. 2, p. 11
- By:
- Publication type:
- Article
7
Frankenfish … It's What's for Dinner: The FDA, Genetically Engineered Salmon, and the Flawed Regulation of Biotechnology.
- Published in:
- Columbia Journal of Law & Social Problems, 2011, v. 45, n. 5, p. 83
- By:
- Publication type:
- Article
8
Broader Implications of Eliminating FDA Jurisdiction Over Execution Drugs.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
9
Customized Medicine and the Limits of Federal Regulatory Power.
- Published in:
- Vanderbilt Journal of Entertainment & Technology Law, 2017, v. 19, n. 2, p. 285
- By:
- Publication type:
- Article
10
PULLING OUR HAIR OUT AND GLOSSING OVER THE PROBLEM: A CALL TO STRENGTHEN THE FDA'S POWER TO REGULATE COSMETICS THROUGH AN AMENDMENT TO THE FEDERAL FOOD, DRUG, AND COSMETIC ACT.
- Published in:
- University of Pittsburgh Law Review, 2017, v. 79, n. 2, p. 317, doi. 10.5195/lawreview.2017.549
- By:
- Publication type:
- Article
11
NO "E"-ASY WAY OUT: WHY THE FDA SHOULD NOT REGULATE E-CIGARETTES UNDER THE CURRENT TCA FRAMEWORK, EVEN WITH NEW DEEMING REGULATIONS.
- Published in:
- University of Pittsburgh Law Review, 2017, v. 79, n. 1, p. 127, doi. 10.5195/lawreview.2017.527
- By:
- Publication type:
- Article
12
A SUPERSIZED SOLUTION TO SUPERBUGS: PREVENTING A POST-ANTIBIOTIC ERA BY OPTIMIZING CONSUMER DEMAND.
- Published in:
- University of Pittsburgh Law Review, 2015, v. 76, n. 4, p. 569, doi. 10.5195/lawreview.2015.363
- By:
- Publication type:
- Article
13
THE NEED FOR FEDERAL PREEMPTION OF STATE TORT CLAIMS IN THE CONTEXT OF "NEW DRUGS" AND PREMARKET-APPROVED MEDICAL DEVICES.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
14
REGULATING THROUGH RULES: SUGGESTED CHANGES IN THE FEDERAL REGULATION OF VETERINARY COMPOUNDING.
- Published in:
- Houston Journal of Health Law & Policy, 2012, v. 13, n. 1, p. 129
- By:
- Publication type:
- Article
15
Food with integrity?: How Responsible Corporate Officer Prosecutions Under the Federal Food, Drug, and Cosmetic Act Deny Fair Warning to Corporate Officers.
- Published in:
- Arkansas Law Review (1968-present), 2017, v. 70, n. 2, p. 449
- By:
- Publication type:
- Article
16
Fresh from the Freezer: Exploring the "Knead" for Transparent Bread Labeling.
- Published in:
- Arizona State Law Journal, 2021, v. 53, n. 4, p. 1359
- By:
- Publication type:
- Article
17
SAFEGUARDING THE RIGHT TO TRY.
- Published in:
- Arizona State Law Journal, 2017, v. 49, n. 2, p. 513
- By:
- Publication type:
- Article
18
Cricket Soup: A Critical Examination of the Regulation of Insects as Food.
- Published in:
- Yale Law & Policy Review, 2017, v. 36, n. 1, p. 17
- By:
- Publication type:
- Article
19
CANNABIS CONSIDERATIONS FOR HEALTH CARE ENTITIES.
- Published in:
- Journal of Health Care Law & Policy, 2021, v. 24, n. 1, p. 89
- By:
- Publication type:
- Article
20
RETHINKING RISKS: SHOULD SOCIOECONOMIC AND ETHICAL CONSIDERATIONS BE INCORPORATED INTO THE REGULATION OF GENETICALLY MODIFIED CROPS?
- Published in:
- Harvard Journal of Law & Technology, 2012, v. 26, n. 1, p. 375
- By:
- Publication type:
- Article
21
POM WONDERFUL V. COCA-COLA AND THE IMPLICATIONS OF GRANTING COMPETITORS THE RIGHT TO CHALLENGE FALSE OR MISLEADING FOOD AND BEVERAGE LABELS UNDER THE LANHAM ACT.
- Published in:
- Loyola of Los Angeles Law Review, 2014, v. 48, n. 2, p. 525
- By:
- Publication type:
- Article
22
Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies.
- Published in:
- BMC Health Services Research, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1472-6963-13-27
- By:
- Publication type:
- Article
23
The FDA's Power Over Non-Therapeutic Uses of Drugs and Devices.
- Published in:
- Washington & Lee Law Review, 2021, v. 78, n. 1, p. 379
- By:
- Publication type:
- Article
24
Pharmaceutical Efficacy: The Illusory Legal Standard.
- Published in:
- Washington & Lee Law Review, 2013, v. 70, n. 4, p. 2073
- By:
- Publication type:
- Article
25
FDA REGULATION OF <sub>3</sub>D-PRINTED ORGANS AND ASSOCIATED ETHICAL CHALLENGES.
- Published in:
- University of Pennsylvania Law Review, 2018, v. 166, n. 2, p. 515
- By:
- Publication type:
- Article
26
Regulating Unknown Risks.
- Published in:
- Regulation, 2010, v. 33, n. 1, p. 16
- By:
- Publication type:
- Article
27
STATE FOOD, DRUG AND COSMETIC LEGISLATION AND ITS ADMINISTRATION.
- Published in:
- Law & Contemporary Problems, 1939, v. 6, n. 1, p. 165, doi. 10.2307/1189735
- By:
- Publication type:
- Article
28
CONSUMERS APPRAISE THE FOOD, DRUG, AND COSMETIC ACT.
- Published in:
- Law & Contemporary Problems, 1939, v. 6, n. 1, p. 144, doi. 10.2307/1189733
- By:
- Publication type:
- Article
29
THE FEDERAL FOOD LEGISLATION OF 1938 AND THE FOOD INDUSTRY.
- Published in:
- Law & Contemporary Problems, 1939, v. 6, n. 1, p. 129, doi. 10.2307/1189732
- By:
- Publication type:
- Article
30
Elixirs, diluents, and the passage of the 1938 Federal, Food, Drug and Cosmetic Act.
- Published in:
- Annals of Internal Medicine, 1995, v. 122, n. 6, p. 456, doi. 10.7326/0003-4819-122-6-199503150-00009
- By:
- Publication type:
- Article
31
UNITED STATES FOOD LAW UPDATE: HEALTH CARE REFORM, PREEMPTION, LABELING CLAIMS AND UNPAID INTERNS: THE LATEST BATTLES IN FOOD LAW.
- Published in:
- Journal of Food Law & Policy, 2010, v. 6, n. 2, p. 311
- By:
- Publication type:
- Article
32
Learning from the Past and Building for the Future: Corporate Integrity Agreements in the Life Sciences Industry.
- Published in:
- Journal of Health Care Compliance, 2013, v. 15, n. 4, p. 27
- By:
- Publication type:
- Article
33
Update on Recent FDA Activities and their Impact on Mobile Apps.
- Published in:
- Journal of Health Care Compliance, 2012, v. 14, n. 5, p. 59
- By:
- Publication type:
- Article
34
THE INTERPLAY BETWEEN FDA AND PATENT LAW: INFUSING ORGANIZATIONAL KNOWLEDGE FOR MEDICAL DEVICE COMPANIES.
- Published in:
- William Mitchell Law Review, 2013, v. 39, n. 4, p. 1176
- By:
- Publication type:
- Article
35
BE CAREFUL WHAT YOU ASK FOR: THE FDA'S DENIALS OF CITIZEN PETITIONS CONFIRMS THERE IS NO SUCH THING AS A LIMITED PREMARKET APPROVAL.
- Published in:
- William Mitchell Law Review, 2013, v. 39, n. 4, p. 1157
- By:
- Publication type:
- Article
36
KNOWLEDGE IS POWER: THE FEDERAL GOVERNMENT MUST REQUIRE COMPANIES TO TELL MENSTRUATORS THE INGREDIENTS IN PERIOD PRODUCTS.
- Published in:
- Hofstra Law Review, 2021, v. 49, n. 4, p. 1051
- By:
- Publication type:
- Article
37
THE FEDERAL FOOD, DRUG, AND COSMETIC ACT OF 1938.
- Published in:
- Journal of Marketing, 1941, v. 5, n. 3, p. 259, doi. 10.2307/1246669
- By:
- Publication type:
- Article
38
News From the Food and Drug Administration.
- Published in:
- JAMA: Journal of the American Medical Association, 2017, v. 317, n. 3, p. 247, doi. 10.1001/jama.2016.19774
- By:
- Publication type:
- Article
39
Getting More Patent Term: Luck and Thought.
- Published in:
- Advocate (05154987), 2022, v. 65, n. 9, p. 22
- By:
- Publication type:
- Article
40
SUBSTANTIALLY UNEQUIVALENT: REFORMING FDA REGULATION OF MEDICAL DEVICES.
- Published in:
- University of Illinois Law Review, 2014, v. 2014, n. 4, p. 1363
- By:
- Publication type:
- Article
41
Health Claims Regulation: Balancing Commercial Free Speech and Consumer Protection.
- Published in:
- University of Chicago Legal Forum, 2013, p. 591
- By:
- Publication type:
- Article
42
OFF-LABEL DRUG ADVERTISING AND THE FIRST AMENDMENT.
- Published in:
- Wake Forest Law Review, 2015, v. 50, n. 1, p. 81
- By:
- Publication type:
- Article
43
WEIRD SCIENCE: FRANKENSTEIN FOODS AND STATES AS LABORATORIES OF DEMOCRACY.
- Published in:
- Journal of Law & Health, 2017, v. 30, n. 1, p. 111
- By:
- Publication type:
- Article
44
Sanctions in Silhouette: An Inquiry Into the Enforcement of the Federal Food, Drug and Cosmetic Act.
- Published in:
- California Law Review, 1963, v. 51, n. 1, p. 38, doi. 10.2307/3478903
- By:
- Publication type:
- Article
45
Celebrity Drug Endorsements: Are Consumers Protected?
- Published in:
- 2017
- By:
- Publication type:
- journal article
46
AIDS Activists, FDA Regulation, and the Amendment of America's Drug Constitution.
- Published in:
- 2016
- By:
- Publication type:
- journal article
47
Cells as Drugs?: Regulating the Future of Medicine.
- Published in:
- American Journal of Law & Medicine, 2014, v. 40, n. 2/3, p. 298, doi. 10.1177/009885881404000208
- By:
- Publication type:
- Article
48
Regulatory Science and the Role of the Regulator in Biomedical Innovation.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
49
Edible Insects and Insect-based Products in the EU: Safety Assessments, Legal Loopholes and Business Opportunities.
- Published in:
- European Journal of Risk Regulation, 2015, v. 6, n. 2, p. 288, doi. 10.1017/S1867299X00004591
- By:
- Publication type:
- Article
50
Cultivating Evidence‐Based Pathways for Cannabis Product Development: Implications for Consumer Protection<sup>†</sup>.
- Published in:
- American Business Law Journal, 2020, v. 57, n. 4, p. 773, doi. 10.1111/ablj.12173
- By:
- Publication type:
- Article